Clinical Trials
All Clinical Trials - Page 63 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00872378Phase 2/Phase 3Unknown
The Effects of Exenatide After Gastric Restriction
Exenatide
- NCT02090673N/ACompleted
Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
Exenatide
- NCT01798264Phase 1Completed
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
Exenatide
- NCT00781911Phase 2Completed
A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
Octreotide
- NCT00842348Phase 3Completed
Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour
Lanreotide
- NCT00902265N/ACompleted
Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)
Desmopressin
- NCT00806468Phase 4Terminated
Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease
Desmopressin
- NCT00805935Phase 4Completed
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
Gonadorelin
- NCT00826839Phase 4Withdrawn
Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients
Gonadorelin
- NCT00835848Phase 4Completed
Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
Exenatide
- NCT01107717Phase 4Completed
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
Exenatide
- NCT01700075Phase 4Completed
Physical and Chemical Study of Atherosclerosis Mechanisms
Exenatide
- NCT00579150N/ATerminated
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
Exenatide
- NCT00859534Phase 2Completed
Phase II Solar Urticaria (SU) Pilot Study
Afamelanotide
- NCT00799929N/ACompleted
IVF Clinical Trial of Two Different Treatment Protocols.
Gonadorelin
- NCT00735852Phase 4Completed
Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women
Gonadorelin
- NCT01563809Phase 3Completed
Basal Androgens and LH Needing for Ovarian Stimulation for in Vitro Fertilization
Gonadorelin
- NCT00791479Phase 2Completed
Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
Dulaglutide
- NCT00845507Phase 4Completed
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
Exenatide
- NCT00747786N/ACompleted
Non Interventional Post Marketing Programme in Neuroendocrine Tumours
Lanreotide
- NCT00798967Phase 3Completed
Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
Teduglutide
- NCT00427349Phase 2Completed
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
Octreotide
- NCT00676338Phase 3Completed
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Exenatide
- NCT00819234Phase 2Completed
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
Pramlintide
- NCT00765999Phase 3Completed
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
Linaclotide
- NCT00781937Phase 3Completed
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
Liraglutide
- NCT00769795Phase 2Completed
Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer
Ghrp-6
- NCT00788320N/AWithdrawn
Vitamin D in Active Tuberculosis (TB) Study
Ll-37
- NCT00761540Phase 1Completed
To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo
Liraglutide
- NCT00765817Phase 3Completed
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
Exenatide
- NCT00753896Phase 3Completed
Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
Exenatide
- NCT00775684N/ACompleted
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
Exenatide
- NCT00741182Phase 2Withdrawn
Effect of PTH(1-34) Treatment on Fracture Healing in Vivo
Teriparatide
- NCT00701363Phase 4Completed
Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects
Lanreotide
- NCT01006954Phase 3Completed
Outcome of Two Protocols in Poor Responders in Assisted Reproductive Technology (ART) Cycle
Gonadorelin
- NCT00924807Phase 1/Phase 2Terminated
Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer
Gonadorelin
- NCT01389713N/ACompleted
Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve
Gonadorelin
- NCT01078545N/ACompleted
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
Gonadorelin
- NCT00782418Phase 1Completed
A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
Exenatide
- NCT00763451Phase 3Completed
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Lixisenatide
- NCT00763815Phase 3Completed
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
Lixisenatide
- NCT00759772Phase 2Completed
The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
Teriparatide
- NCT00789841N/ACompleted
Gastrointestinal Motility in Patients With Neuroendocrine Tumors
Octreotide
- NCT00765323Phase 3Terminated
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
Octreotide
- NCT01222598N/ACompleted
A Study of Minirin Melt in Patients With Nocturia
Desmopressin
- NCT00765882Phase 3Completed
Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
Linaclotide
- NCT00730171Phase 3Completed
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
Linaclotide
- NCT00697463Phase 2/Phase 3Completed
Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
Teriparatide
- NCT04425746Phase 2Completed
Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer Sodium
Afamelanotide
- NCT00740831Phase 3Completed
PGL4001 Versus GnRH-agonist in Uterine Myomas
Gonadorelin